Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07261501Recruiting
Antibacterial dressing for chronic wounds
This study tests a new absorbable wound dressing that fights bacteria to help heal chronic wounds that haven't improved for at least a week. It might be a good option if you have a wound that's infected or has bacteria on it and is between the size of a coin and a small plate.
Beijing, Beijing MunicipalityAges 1.5 years–80 years - NCT06814964RecruitingPhase 1
Intraventricular clot removal with medication after brain bleed
This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.
Beijing, Beijing MunicipalityAges 18–80 - NCT06936488Enrolling by invitation
Study of Ivonescimab with TAS-102 for advanced colorectal cancer
This trial tests a combination of two drugs – ivonescimab (a type of immunotherapy) and TAS-102 (a chemotherapy) – for people with advanced colorectal cancer that has not responded to at least two prior chemotherapies. The goal is to see if this new combo can shrink tumors or slow cancer growth.
Huai'an, JiangsuAges 18–75 - NCT06676722RecruitingPhase 2
SBRT and two targeted drugs for advanced nasopharyngeal cancer
This trial tests a combination of focused radiation (SBRT) and two targeted drugs (nimotuzumab and tislelizumab) for people with nasopharyngeal cancer that has come back or spread to a few spots (1-5) after prior immunotherapy. It aims to see if this triple therapy can help control the disease when standard treatment has stopped working.
Xiamen, FujianAges 18–75 - NCT06540326RecruitingPhase 2
Second-line therapy for advanced colorectal cancer
This trial tests a combination of chemotherapy with either bevacizumab or cetuximab as a second-line treatment for advanced colorectal cancer. It aims to find which option works better for patients whose first treatment failed.
Hangzhou, ZhejiangAges 18–75 - NCT06091085RecruitingPhase 1/Phase 2
Acetazolamide for sleep apnea in untreated patients
This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.
Boston, MassachusettsAges 21–80 - NCT06844604Recruiting
Comparing carbon footprint of robotic, laparoscopic, and open colorectal surgery
This study measures the environmental impact (carbon footprint) of different surgical techniques for removing part of the colon or rectum. It aims to find which approach is more sustainable without compromising patient care.
BaselAges 18 years+ - NCT07198659RecruitingEarly Phase 1
New immune cell therapy for advanced pancreatic cancer
This trial tests a new treatment using your own immune cells (called neutrophils) that are loaded with a drug to fight pancreatic cancer that cannot be removed by surgery. It may be an option if standard treatments have stopped working or caused bad side effects.
Xi’an, ShanxiAges 18–70 - NCT07198438Enrolling by invitation
Deep vs standard brain stimulation for depression
This trial compares two types of brain stimulation (deep vs standard theta burst stimulation) to see which works better for people with depression who haven't gotten enough help from antidepressant medication. It aims to find a more effective treatment option.
Douliu, Yunlin CountyAges 18–70 - NCT07197970RecruitingPhase 3
Stent for blocked brain arteries
This trial tests whether a drug-coated stent can help people with severely narrowed brain arteries that have already caused a stroke or mini-stroke. It aims to improve blood flow and prevent future strokes.
Beijing, Beijing MunicipalityAges 18–80 - NCT07258771RecruitingPhase 4
Upadacitinib plus steroids vs steroids alone for severe ulcerative colitis
This trial tests if adding upadacitinib (a pill) to standard steroid treatment helps people with a severe flare of ulcerative colitis feel better faster. You may qualify if you are having frequent bloody stools and signs of serious inflammation, and you haven't tried upadacitinib before.
Ann Arbor, MichiganAges 18–75 - NCT07450092Enrolling by invitation
Prehospital use of forced air warming
This trial tests if using a forced air warming blanket before reaching the hospital can help healthy adults. It aims to see if keeping people warm during transport improves outcomes.
BergenAges 18–45 - NCT06845579Recruiting
Predicting blood pressure results after kidney nerve treatment
This study tests a treatment called renal denervation, which uses a special procedure to calm nerves near the kidneys that can raise blood pressure. It may help people whose high blood pressure is not well controlled despite taking several medications.
Mainz, Rheinland PflanzAges 18 years+ - NCT07193836Enrolling by invitation
Lidocaine for easier recovery after laparoscopic surgery
This study tests whether giving lidocaine (a numbing medicine) through an IV can help you wake up more smoothly and with less discomfort after laparoscopic gallbladder or gynecologic surgery. If you are generally healthy and having one of these specific surgeries, you may be a good fit.
Yinchuan, NingxiaAges 18–70 - NCT06826092RecruitingPhase 2
Metformin for advanced colorectal cancer with chemotherapy
This trial tests whether adding metformin (a diabetes drug) to standard chemotherapy (FOLFIRI) and targeted therapy can help people with metastatic colorectal cancer live longer or respond better to treatment.
Kaohsiung CityAges 20–90 - NCT07552051Recruiting
Testing Bite Mark Analysis Using 3D Dental Scans
This study tests how accurately dentists can analyze bite marks using digital 3D models of teeth. Researchers will scan your upper teeth and use computer software to see if the same bite-mark patterns are found consistently—helping improve how bite marks are used in dental and legal cases.
Nantes, NantesAges 18 years+ - NCT06874452RecruitingPhase 4
Anti-anxiety pill for second cataract surgery
This study tests if giving the anti-anxiety pill alprazolam (XANAX) before your second cataract surgery helps reduce anxiety and improve satisfaction with the procedure.
TaipeiAges 18–80 - NCT07191782Recruiting
Testing the PRAISE with Coaching Program in Schools
This study tests a program called PRAISE that helps teachers support students' social and emotional skills. It may help your child feel more connected and do better in school.
Philadelphia, PennsylvaniaAges 8 years+ - NCT06660511RecruitingEarly Phase 1
Combination therapy for HER2-positive platinum-resistant ovarian cancer
This trial tests a combination of two drugs—Disitamab Vedotin and Anlotinib—for patients with ovarian cancer that has come back after platinum chemotherapy. It is designed for people whose tumors show a specific protein called HER2, and it aims to see if the combination is safe and effective.
Changsha, HunanAges 18 years+ - NCT07374393Enrolling by invitation
Sleep study for people with brain disorders
This study looks at sleep and sleep problems in people with neurological conditions like stroke, Parkinson's, epilepsy, or memory issues. You will do a one-night sleep test (polysomnography) and answer questionnaires to help researchers understand your sleep and daytime function.
Changchun, JilinAges 14–80 - NCT05789043RecruitingPhase 3
Test of immunotherapy plus pills and chemotherapy for advanced melanoma
This Phase 3 trial tests camrelizumab (an immune-boosting medicine) combined with apatinib (a targeted pill) and temozolomide (chemotherapy) as first treatment for advanced acral melanoma. It may help shrink the cancer and improve outcomes compared with other standard first-line options.
BeijingAges 18 years+ - NCT07177612Enrolling by invitation
Testing the LILAC method for lipoprotein(a) education
This trial tests a new method called LILAC to help people learn about and manage high levels of lipoprotein(a), a type of fat in the blood. It is for anyone 16 or older who attends educational events or is part of a health group.
PerthAges 16 years+ - NCT07188350Recruiting
Electrical muscle stimulation for patients on a breathing machine
This trial tests whether low-level electrical pulses to the leg muscles can help prevent weakness in patients who need a breathing tube (ventilator) for more than 48 hours. It aims to see if this treatment helps patients recover faster.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07188220Recruiting
Understanding patient views on fatty liver disease study
This study asks people with metabolic fatty liver disease and liver scarring about their experiences. It aims to learn what matters to you so doctors can improve care.
BarcelonaAges 18–75
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.